株式市場ニュース
最新の金融ニュース · 更新 7月 26, 2026
私の2026年5月購入すべき最近のトップ2のテックIPO
My Top 2 Recent Tech IPOs to Buy for May 2026
The panel consensus is bearish on both Circle (CRCL) and CoreWeave (CRWV), citing existential regulatory risks, reliance on a few …
Galaxy-Backed Boundary、USBDステーブルコインをローンチへ
Galaxy-Backed Boundary To Launch USBD Stablecoin
Despite the potential of daily on-chain verification, Boundary Labs' USBD stablecoin faces significant challenges in liquidity, regulatory compliance, and operational …
Radiant Logistics は FQ3 の予想を上回る
Radiant Logistics beats FQ3 expectations
Despite a clean EPS beat, Radiant Logistics' (RLGT) operational margins eroded significantly, and international headwinds pose substantial risks to its …
「ビッグ・ショート」の投資家マイケル・バーリー氏、「市場は『ジャンプ・ザ・シャーク』した」と発言 — 投資家が間違っていると指摘する点
'Big Short' investor Michael Burry says the market has 'jumped the shark' — what he says investors are getting wrong
Panelists agree that while the current market has notable concentration risk and high valuations, it may persist due to structural …
Chardan、Iovance（IOVA）の目標株価を下方修正、Buyレーティングは維持
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
While IOVA's Q1 revenue growth is impressive, the panelists have mixed views on its sustainability and profitability. The price target …
CanaccordはQ1のハイライトを受けてTaysha (TSHA)の買いレーティングを維持
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights
The panelists have mixed views on TSHA's potential. While some see promise in the FDA alignment and the addressable market, …
H.C. Wainwright および Wells Fargo、MannKind (MNKD) の目標株価を引き上げ
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
The panelists agree that MannKind's (MNKD) valuation hinges on the success of its royalty streams, particularly from Tyvaso DPI, and …
1 ウォール街のトップアナリストは、CRISPRセラピューティクスが2倍以上になる可能性があると考えています。今すぐ株を手に取るべきでしょうか？
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
CRISPR Therapeutics' stock performance is driven by optimism around CTX611 and oncology candidates, but faces significant risks including complex manufacturing, …
ガーロン（GERN）は5ドル以下の米国株で最高の株の一つですか？
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
Geron's (GERN) commercial success hinges on RYTELO's adoption curve and potential label expansion. While Q1 2026 revenue of $51.8M shows …
韓国電力 Q1 利益増加
Korea Electric Power Q1 Earnings Rise
The panel consensus is bearish, with all participants expressing concerns about KEP's earnings growth, margin compression, and significant debt servicing …
SKイノベーション、第1四半期に黒字を計上
SK Innovation Reports Profit In Q1
SK Innovation's Q1 results show a dramatic turnaround, but sustainability is uncertain due to the lack of segment breakdown and …
12ヶ月後、今日ブルームエナジーを買っておけばよかったと思うだろうか？
12 Months From Now, Will You Wish You Bought Bloom Energy Today?
The panel consensus is bearish on Bloom Energy, citing its high valuation, reliance on natural gas, and execution risks in …